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The human intestinal flora is a highly diverse and complex microbial ecosystem. This microbiome 
changes drastically in CF patients due to the frequent and combined antibiotic usage. Moreover, the 
decreased release of digestive enzymes by the pancreatic duct leads to a different alimentary environment 
in which the microbial system resides. A shotgun metaproteomics approach is used to characterize the 
predominant members of the intestinal microbiota of a group of cystic fibrosis patients compared with the 
flora of siblings.  
 
The aim of this study was to evaluate a metaproteomics pipeline (gel-LC-ESI-FT-MS/MS) on secretome 
and proteome samples extracted from feces of a CF patient and its sibling. These two fractions, proteome 
and secretome were separated by 12.5 % SDS-PAGE. After reduction and alkylation, the complete lanes 
were cut from the gel and sliced into 6 bands per lane. Each band was in-gel digested as previously 
described (Vanrobaeys et al., 2005). Peptides were first separated on an Agilent 1200 chromatographic 
system (Agilent, Santa Clara, CA, USA) and on-line measured on a LTQ-FT Ultra mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA, USA). Raw LC-ESI-FT-MS/MS data were searched against 
the NCBInr database and a decoy database using Mascot Daemon. The characterization of the 
predominant members of the intestinal microbiota was performed using a novel approach for identifying 
taxon-specific peptides (Unipept). 
 
Our preliminary data point to a decrease in species richness and in less unique peptides originating from 
Firmicutes, Proteobacteria and the Bacteroidetes/Chlorobium group in the microbiota of the CF patient 
compared to the sibling. Similar findings are also reported in a recent microbiological study 
(Duytschaever et al, 2011) on fecal samples of CF patients.  Furthermore, the detection of unique peptides 
of Viridiplantae indicates incomplete digestion of food in the intestinal tract. The unique peptides from 
Sus scrofa in the CF patient can be explained by the presence of pancreatin, a mixture of the pancreatic 
enzymes lipase, amylase and protease extracted from pig (Sus scrofa) pancreas glands.  
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